D. Poli

发表

External validation of the DASH prediction rule: a retrospective cohort study

W. Ageno, F. Dentali, A. Tosetto, 2017, Journal of thrombosis and haemostasis : JTH.

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data

J. Douketis, A. Iorio, M. Cushman, 2015, Journal of thrombosis and haemostasis : JTH.

Comparison between different D‐Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study

A. Tosetto, S. Testa, D. Poli, 2016, International journal of laboratory hematology.

Modelling of spaceborne linear array sensors

D. Poli, Daniela Poli, 2005 .

The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.

R. Abbate, G. Gensini, D. Poli, 2009, International journal of cardiology.

Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinics

A. Tosetto, D. Poli, E. Morra, 2007, Internal and emergency medicine.

Off-label use of reduced dose direct oral factor Xa-inhibitors in subjects with atrial fibrillation: a review of clinical evidence.

D. Poli, N. Marchionni, M. Bo, 2020, European heart journal. Cardiovascular pharmacotherapy.

Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET.

E. Grandone, S. Testa, D. Poli, 2020, Blood transfusion = Trasfusione del sangue.

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry

W. Ageno, E. Grandone, F. Violi, 2019, Journal of the American Heart Association.

Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study.

R. de Caterina, S. Testa, D. Poli, 2018, International journal of cardiology.

Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants

R. Testa, S. Testa, D. Poli, 2018, Journal of thrombosis and haemostasis : JTH.

Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics.

R. Abbate, S. Testa, D. Poli, 2016, Thrombosis research.

Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.

R. Abbate, G. Gensini, D. Poli, 2009, Journal of the American College of Cardiology.

Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment: Results of a Prospective Collaborative Study on Elderly Patients Followed by Italian Centres for Anticoagulation

W. Ageno, A. Tosetto, S. Testa, 2011, Circulation.

Culprit Factors for the Failure of Well-Conducted Warfarin Therapy to Prevent Ischemic Events in Patients With Atrial Fibrillation: The Role of Homocysteine

R. Abbate, G. Gensini, D. Poli, 2005, Stroke.

Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.

R. Abbate, G. Gensini, D. Poli, 2007, Thrombosis research.

Stroke risk in atrial fibrillation patients on warfarin

R. Abbate, G. Gensini, D. Poli, 2009, Thrombosis and Haemostasis.

Warfarin prescription in patients with nonvalvular atrial fibrillation and one non–gender‐related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma

S. Testa, D. Poli, E. Antonucci, 2018, Cardiovascular therapeutics.

Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in Patients With Atrial Fibrillation.

S. Testa, D. Poli, E. Antonucci, 2017, The American journal of cardiology.

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago

W. Ageno, M. Moia, A. Tosetto, 2017, Internal and Emergency Medicine.

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

N. Magrini, A. Tosetto, D. Poli, 2015, PloS one.

Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.

G. Lip, S. Testa, D. Poli, 2011, Chest.

Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register

W. Ageno, G. Lessiani, G. Biolo, 2022, Internal and Emergency Medicine.

Association of Antiplatelet and Anticoagulant Treatment in Patients with Mechanical Prosthetic Heart Valves. Data from the Observational Multicentre PLECTRUM Study

S. Testa, D. Poli, C. Lodigiani, 2021, Cardiology and Cardiovascular Medicine.

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis

J. Douketis, A. Iorio, M. Cushman, 2010, Journal of thrombosis and haemostasis : JTH.

Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study

S. Iliceto, S. Testa, D. Poli, 2013, Journal of Thrombosis and Thrombolysis.

The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures

M. Moia, S. Testa, D. Poli, 2018, Internal and Emergency Medicine.

The SAMe-TT2R2 score and quality of anticoagulation in AF: Can we predict which patient benefits from anticoagulation?

L. Fauchier, D. Poli, B. Olshansky, 2015, Thrombosis and Haemostasis.

Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register

W. Ageno, S. Testa, D. Poli, 2021, Therapeutic advances in drug safety.

Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register

F. Pomero, W. Ageno, F. Dentali, 2021, TH Open.

Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study.

M. Margaglione, W. Ageno, S. Testa, 2020, Blood transfusion = Trasfusione del sangue.

Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution.

F. Dentali, A. Fontanella, S. Testa, 2019, European journal of internal medicine.

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

W. Ageno, P. Prandoni, A. Tosetto, 2018, Journal of thrombosis and haemostasis : JTH.

Response to Letter Regarding Article, “Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment: Results of a Prospective Collaborative Study on Elderly Patients Followed by Italian Centres for Anticoagulation”

W. Ageno, S. Testa, D. Poli, 2012 .

, Centres for Anticoagulation of a Prospective Collaborative Study on Elderly Patients Followed by Italian Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment : Results

W. Ageno, A. Tosetto, S. Testa, 2011 .

Clinical Presentation of Acute Pulmonary Embolism: Survey of 800 Cases

D. Poli, S. Monti, M. Miniati, 2012, PloS one.

Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs.

W. Ageno, S. Testa, D. Poli, 2020, European journal of internal medicine.

The incidence of recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension following a first episode of pulmonary embolism

D. Poli, M. Miniati, 2011, Current opinion in pulmonary medicine.

Assessing recurrence risk following acute venous thromboembolism: use of algorithms

D. Poli, G. Palareti, 2013, Current opinion in pulmonary medicine.

Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion

R. Abbate, D. Poli, R. Marcucci, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences.

J. Douketis, Catrin Tudur Smith, A. Iorio, 2013, Journal of clinical epidemiology.

Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study

W. Ageno, A. Tosetto, S. Testa, 2015, Journal of thrombosis and haemostasis : JTH.

Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM study

S. Testa, D. Poli, C. Lodigiani, 2018, Open Heart.

Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real‐practice of an anticoagulation clinic

R. Abbate, G. Gensini, V. Boddi, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism

J. Douketis, D. Poli, T. Baglin, 2008, Annals of Internal Medicine.

Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants

R. Testa, S. Testa, D. Poli, 2019, Journal of thrombosis and haemostasis : JTH.

Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.

A. Iorio, S. Testa, D. Poli, 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study.

A. Tosetto, S. Testa, D. Poli, 2010, Blood.

Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study

A. Tosetto, S. Testa, D. Poli, 2010, Thrombosis and Haemostasis.

Sex, age and normal post‐anticoagulation D‐dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension

A. Tosetto, S. Testa, D. Poli, 2010, Journal of thrombosis and haemostasis : JTH.

Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study

A. Tosetto, D. Poli, B. Cosmi, 2009, Journal of Thrombosis and Thrombolysis.

Combination of D‐dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal

R. Abbate, D. Poli, E. Antonucci, 2008, Journal of thrombosis and haemostasis : JTH.

Risks factors for highly unstable response to oral anticoagulation: a case‐control study

G. Marchetti, D. Poli, B. Cosmi, 2005, British journal of haematology.

High Rate of Recurrence in Renal Transplant Recipients after a First Episode of Venous Thromboembolism

M. Salvadori, G. Gensini, D. Poli, 2005, Transplantation.

Asymptomatic excessive coumarin anticoagulation is a risk factor for thrombotic and bleeding complications of oral anticoagulant therapy

R. Abbate, G. Gensini, D. Poli, 2003, Journal of thrombosis and haemostasis : JTH.

Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism

R. Abbate, G. Gensini, D. Poli, 2003, Thrombosis and Haemostasis.

The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE

G. Lip, S. Testa, D. Poli, 2016, Thrombosis and Haemostasis.

A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin

S. Testa, D. Poli, E. Antonucci, 2014, Internal and Emergency Medicine.

Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper

J. Douketis, E. Grandone, M. Moia, 2021, Thrombosis and Haemostasis.

Erythrocytosis and severe asphyxia: two different causes of neonatal myocardial infarction

D. Poli, P. Guccione, E. Caruso, 2013, Cardiology in the Young.

Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

S. Testa, D. Poli, E. Antonucci, 2022, Bleeding, Thrombosis, and Vascular Biology.

Determinants of low‐quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study

G. Lip, F. Violi, D. Poli, 2020, British journal of haematology.

Thrombophilic Risk Factors in Patients with Central Retinal Vein Occlusion

B. Giusti, R. Abbate, L. Bertini, 2001, Thrombosis and Haemostasis.

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

J. Le Heuzey, J. Healey, J. Camm, 2019, Thrombosis Journal.

The negative predictive value of D‐dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: A prospective cohort study (the PROLONG PLUS study)

W. Ageno, F. Dentali, D. Poli, 2012, American journal of hematology.

The prevention of venous thromboembolism recurrence in the elderly: a still open issue

D. Poli, G. Palareti, 2018, Expert review of hematology.

Risk of recurrence in patients with pulmonary embolism: Predictive role of D-dimer and of residual perfusion defects on lung scintigraphy

R. Abbate, D. Poli, E. Antonucci, 2012, Thrombosis and Haemostasis.

Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism

R. Abbate, D. Poli, E. Antonucci, 2010, Journal of Thrombosis and Thrombolysis.

Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism.

B. Giusti, A. Gori, R. Abbate, 2003, The American journal of medicine.

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply

W. Ageno, A. Tosetto, D. Poli, 2018, Journal of thrombosis and haemostasis : JTH.

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

W. Ageno, P. Prandoni, N. Magrini, 2019, Internal and Emergency Medicine.

The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study: reply

W. Ageno, S. Testa, D. Poli, 2014, Journal of Thrombosis and Haemostasis.

Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL.

W. Ageno, G. Lippi, M. Moia, 2018, Blood transfusion = Trasfusione del sangue.

Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases.

W. Ageno, F. Dentali, F. Passamonti, 2014, Thrombosis research.

Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination

R. Abbate, G. Gensini, D. Poli, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.

S. Testa, D. Poli, B. Cosmi, 2013, Thrombosis and haemostasis.

Duration of anticoagulation after isolated pulmonary embolism

P. Prandoni, A. Tosetto, S. Testa, 2016, European Respiratory Journal.

Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation.

R. Abbate, G. Gensini, D. Poli, 2003, Haematologica.

Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and meta‐analysis

J. Douketis, M. Cushman, M. Marcucci, 2022, British journal of haematology.

Oral anticoagulant management of patients with mechanical heart valves at the Salam Centre of Khartoum: Observations on quality of anticoagulation and thrombotic risk.

A. Tosetto, S. Testa, D. Poli, 2022, Thrombosis research.

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study

R. Abbate, S. Testa, D. Poli, 2016, Journal of thrombosis and haemostasis : JTH.

New anticoagulant drugs: a turning point in oral anticoagulation management?

D. Poli, E. Grifoni, D. Prisco, 2009 .

Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry

W. Ageno, F. Dentali, E. Grandone, 2012 .

Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS.

G. La Manna, D. Poli, E. Antonucci, 2020, Thrombosis research.

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism

W. Ageno, P. Prandoni, A. Bignamini, 2020, Internal and Emergency Medicine.

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results

W. Ageno, P. Prandoni, A. Tosetto, 2022, Bleeding, Thrombosis, and Vascular Biology.

Clotting activation after oral anticoagulant therapy discontinuation: a risk factor for recurrent venous thromboembolism

R. Abbate, G. Gensini, D. Poli, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Anticoagulation quality and the risk of recurrence of venous thromboembolism.

R. Abbate, D. Poli, E. Antonucci, 2007, Thrombosis and haemostasis.

Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA).

A. Tosetto, S. Testa, D. Poli, 2011, Thrombosis and haemostasis.

Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation.

A. Tosetto, S. Testa, D. Poli, 2011, Thrombosis and Haemostasis.

D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants

W. Ageno, A. Ciavarella, S. Testa, 2019, PloS one.

W. Ageno, F. Dentali, D. Poli, 2020, Thrombosis research.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis

R. Abbate, M. Salvadori, D. Poli, 2006, Journal of thrombosis and haemostasis : JTH.

The Thrombophilic Pattern of Different Clinical Manifestations of Venous Thromboembolism: A Survey of 443 Cases of Venous Thromboembolism

R. Abbate, D. Poli, R. Marcucci, 2012, Seminars in Thrombosis & Hemostasis.

Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study.

W. Ageno, S. Testa, D. Poli, 2019, Thrombosis research.

Patients With Atrial Fibrillation Prospective Primary Prevention Cohort of Bleeding and Stroke Risk in a Real-world

S. Testa, D. Poli, E. Antonucci, 2011 .

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases

E. Grandone, M. Moia, A. Tosetto, 2020, Internal and Emergency Medicine.

Thrombophilia testing in the real-world clinical setting of thrombosis centres taking part in the Italian Start 2-Register.

W. Ageno, E. Grandone, S. Testa, 2021, Blood transfusion = Trasfusione del sangue.

Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register

W. Ageno, P. Prandoni, D. Poli, 2022, TH open : companion journal to thrombosis and haemostasis.

Management of anticoagulation in hemodialysis: Results from a survey of current clinical practice in the Italian anticoagulation clinics.

E. Grandone, S. Testa, D. Poli, 2022, Thrombosis research.

A guide to oral anticoagulant treatment. Recommendations of the Italian federation of anticoagulation clinics (FCSA)

M. Moia, A. Tosetto, S. Testa, 2003 .

The effect of recanalization on long‐term neurological outcome after cerebral venous thrombosis

W. Ageno, F. Dentali, I. Martinelli, 2018, Journal of thrombosis and haemostasis : JTH.

Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START‐Laboratory Register

S. Testa, D. Poli, B. Cosmi, 2018, International journal of laboratory hematology.

Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study

S. Testa, D. Poli, E. Antonucci, 2021, Molecules.

Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry

D. Poli, E. Antonucci, G. Palareti, 2022, Platelets.

Sex‐based difference in anticoagulated patients with mechanical prosthetic heart valves and long‐term mortality risk

F. Violi, D. Poli, E. Antonucci, 2021, International journal of clinical practice.

Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism

R. Abbate, D. Bani, D. Poli, 2013, Thrombosis and Haemostasis.

The role of cysteine and homocysteine in venous and arterial thrombotic disease.

B. Giusti, R. Abbate, G. Gensini, 2001, American journal of clinical pathology.

Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study

W. Ageno, S. Testa, D. Poli, 2019, PloS one.

Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic.

M. Bottai, R. Abbate, D. Poli, 2010, American journal of respiratory and critical care medicine.

A rare case of prothrombin time prolongation

D. Poli, Niccolò Maggini, Matteo Piccica, 2020, Internal and Emergency Medicine.

Obstetrical history of women with cerebral vein thrombosis: outcome of the pregnancies before and after the thrombotic event

S. Testa, D. Poli, O. Paoletti, 2017, Internal and Emergency Medicine.

Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of d-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism

J. Douketis, A. Iorio, M. Cushman, 2010, Annals of Internal Medicine.

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

Mary Cushman, Alfonso Iorio, James Douketis, 2011, BMJ : British Medical Journal.

Anomalous aortic origin of the pulmonary arteries: Case series and literature review

M. Raponi, A. Secinaro, D. Poli, 2019, Annals of pediatric cardiology.

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention

M. Margaglione, W. Ageno, J. Eikelboom, 2009, American journal of hematology.

Bleeding risk assessment and management in atrial fibrillation patients

P. Kirchhof, G. Lip, L. Fauchier, 2011, Thrombosis and Haemostasis.

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.

John Camm, Paulus Kirchhof, Gregory Y H Lip, 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

The Practical Management of Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy

D. Poli, G. Liumbruno, D. Godoy, 2011, International journal of stroke : official journal of the International Stroke Society.

Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).

W. Ageno, S. Testa, D. Poli, 2013, Thrombosis research.

Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment

R. Abbate, G. Gensini, D. Poli, 2009, Thrombosis and Haemostasis.

The role of anticoagulation clinics needs to be reassessed to include follow up of patients on direct oral anticoagulants.

S. Testa, D. Poli, P. Bucciarelli, 2023, Thrombosis research.

The challenges and limitations of widespread direct oral anticoagulant treatment: practical suggestions for their best use

D. Poli, G. Palareti, 2016, Expert review of cardiovascular therapy.

International Journal of Women's Health Dovepress Epidemiology, Diagnosis, and Management of Atrial Fibrillation in Women

D. Poli, E. Antonucci, 2022 .

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Mehrad Amin Eskandari, J. F. Tinto, A. Capucci, 2018, Indian heart journal.

Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation

P. Heuschmann, J. Martí-Fàbregas, A. Biffi, 2017, Neurology.

Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score

A. Farcomeni, F. Violi, D. Poli, 2016, Internal and Emergency Medicine.

Recurrence of ICH after resumption of anticoagulation with VK antagonists

F. Dentali, S. Testa, D. Poli, 2014, Neurology.

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: A prospective multicenter cohort study

W. Ageno, F. Dentali, D. Poli, 2012, American journal of hematology.

Stroke Risk Stratification in a “Real‐World” Elderly Anticoagulated Atrial Fibrillation Population

G. Lip, D. Lane, D. Poli, 2011, Journal of cardiovascular electrophysiology.

Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results

M. Moia, A. Tosetto, S. Testa, 2012, Journal of thrombosis and haemostasis : JTH.

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.

W. Ageno, F. Dentali, M. Di Nisio, 2015, JAMA internal medicine.

Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis.

W. Ageno, F. Dentali, G. Vidili, 2014, Thrombosis research.

Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry.

W. Ageno, F. Dentali, P. Verhamme, 2016, The Lancet. Haematology.

Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)

J. Douketis, A. Iorio, M. Cushman, 2012, Journal of thrombosis and haemostasis : JTH.

Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study

W. Ageno, F. Dentali, V. Di Lazzaro, 2012, Journal of thrombosis and haemostasis : JTH.

Hemostatic Complications in Renal Transplantation

D. Poli, E. Antonucci, M. Zanazzi, 2017, Seminars in Thrombosis and Hemostasis.

Venous thromboembolism in renal transplant recipients: high rate of recurrence.

R. Abbate, M. Salvadori, G. Gensini, 2005, Transplantation proceedings.

Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy

B. Giusti, A. Gori, D. Poli, 2020, Thrombosis and Haemostasis.

Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy

A. Amodeo, G. Limongelli, F. Drago, 2022, Frontiers in Physiology.

The upper extremity postthrombotic syndrome score: an international Delphi consensus study to determine the score’s functional disability component

J. Douketis, G. Stansby, M. Koelemay, 2023, Research and practice in thrombosis and haemostasis.

Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis

J. Douketis, W. Ageno, F. Dentali, 2013, Thrombosis and Haemostasis.

The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study

W. Ageno, S. Testa, D. Poli, 2013, Journal of thrombosis and haemostasis : JTH.

D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.

P. Prandoni, A. Tosetto, S. Testa, 2014, Blood.

Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry

W. Ageno, P. Verhamme, S. Testa, 2018, Internal and Emergency Medicine.

[Antiphospholipid syndrome and venous thromboembolism: the role of congenital thrombophilia].

G. Gensini, D. Poli, 2005, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.

DOAC plasma levels measured by chromogenic anti‐Xa assays and HPLC‐UV in apixaban‐ and rivaroxaban‐treated patients from the START‐Register

S. Testa, D. Poli, B. Cosmi, 2020, International journal of laboratory hematology.

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

W. Ageno, P. Prandoni, E. Grandone, 2022, Blood advances.

Baseline characteristics and management of patients with splanchnic vein thrombosis: Results of an international registry

W. Ageno, E. Grandone, P. Verhamme, 2012 .

Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis

D. Poli, A. Squizzato, S. Galliazzo, 2023, Internal and Emergency Medicine.

Management of oral anticoagulant therapy in the real practice of an anticoagulation clinic: focus on atrial fibrillation

R. Abbate, G. Gensini, D. Poli, 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Hyperhomocysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation?

B. Giusti, R. Abbate, G. Gensini, 2004, American heart journal.

Hyperhomocysteinemia and vitamin B 6 deficiency: New risk markers for nonvalvular atrial

B. Giusti, R. Abbate, G. Gensini, 2004 .

Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists

W. Ageno, S. Testa, D. Poli, 2012, Thrombosis and Haemostasis.

Management of special conditions in patients on vitamin K antagonists

S. Testa, D. Poli, F. Marongiu, 2012, Internal and Emergency Medicine.

Low Molecular Weight Heparin during Surgery in Parients on Long Term Oral Anticoagulant Treatment (OAT): A Prospective Observational Study.

A. Tosetto, D. Poli, E. Morra, 2004 .

Intracranial hemorrhage recurrence on vitamin K antagonist: severity of the first episode and HASBLED score fail to identify high-risk patients from the CHIRONE study

F. Dentali, S. Testa, D. Poli, 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

W. Ageno, P. Prandoni, A. Tosetto, 2020, BMJ Open.

Management of DOAC in patients undergoing planned surgery or invasive procedure: FCSA position paper

E. Grandone, M. Moia, A. Tosetto, 2021, Thrombosis and Haemostasis.

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data

Pedro F. Campos, Roger A. Nadeau, Jonathan B Sumner, 2021, BMJ.

Peripheral arteriopathy of the lower limbs in a patient with severe congenital thrombocytopenia

P. Noris, G. Gensini, D. Poli, 2006, Internal and emergency medicine.

Hyperviscosity as a possible risk factor for cerebral ischemic complications in atrial fibrillation patients.

R. Abbate, G. Gensini, D. Poli, 2006, The American journal of cardiology.

International Journal of Women's Health Dovepress Epidemiology, Diagnosis, and Management of Atrial Fibrillation in Women

D. Poli, E. Antonucci, 2022 .

epidemiology , diagnosis , and management of atrial fibrillation in women

D. Poli, E. Antonucci, 2015 .

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation.

A. Tosetto, S. Testa, D. Poli, 2011, Thrombosis and Haemostasis.

Combination of D‐dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal

D. Poli, E. Antonucci, G. Ciuti, 2008, Journal of thrombosis and haemostasis : JTH.

Safety Analysis of 13 Suspicious Deaths in Intensive Care: Ergonomics and Forensic Approach Compared

D. Poli, G. Biancofiore, G. Bertolini, 2020, Journal of patient safety.

D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.

P. Prandoni, A. Tosetto, S. Testa, 2014, Blood.

Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

E. Grandone, S. Testa, D. Poli, 2023, Bleeding, Thrombosis, and Vascular Biology.

Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper

D. Poli, P. Bucciarelli, D. Barcellona, 2023, Thrombosis and Haemostasis.

Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score

J. Douketis, M. Cushman, M. Marcucci, 2011 .

Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

W. Ageno, S. Testa, D. Poli, 2023, Bleeding, Thrombosis, and Vascular Biology.

Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes

W. Ageno, M. Di Nisio, L. Carrozzi, 2023, Research and Practice in Thrombosis and Haemostasis.

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

G. Lip, W. Ageno, P. Prandoni, 2018, Journal of Thrombosis and Haemostasis.